MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-KR-03-0167186
Fenestra Pharmaceuticals Private Limited - pharma in Bangalore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹11.43 Cr
▲ 3% YoY
Net loss · FY 2025
₹44,145
Net margin 0%
EBITDA · FY 2025
₹33.13 Lakh
EBITDA margin 2.9%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹22.5 Lakh
Issued & subscribed
Open charges
₹1.38 Cr
Secured borrowings
Company age
15 yrs
Est. 2011
Employees · EPFO
25
Provident fund records
About Fenestra Pharmaceuticals Private Limited
Data last updated:
Fenestra Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 January 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24230KA2011PTC056572. Its GSTIN is 32AABCF6586E1ZQ (Kerala).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹22.5 Lakh. It is led by directors including Nimesh Elayidath (Managing Director) and Jayasankar Panichelparambil Gopalakrishnakurup.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at #751 Ground Floor 8th Cross 4th Main Mc Layout, Bangalore, Karnataka, India – 560040.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.43 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net loss of ₹44,145 (net margin 0%) and EBITDA of ₹33.13 Lakh (EBITDA margin 2.9%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 9% over five years.
The company has about 25 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹1.38 Cr on record.
Fenestra Pharmaceuticals Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-KR-03-0167186). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website fenestra.in.
Company details
CIN U24230KA2011PTC056572
Registration Number 056572
Incorporation Date 10 January 2011
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-KR-03-0167186
Key People
Nimesh Elayidath Managing Director Jayasankar Panichelparambil Gopalakrishnakurup Director Sugunanambiar Bijoy Director Recognitions & Rankings of Fenestra Pharmaceuticals
Contact details
Fenestra Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka. Its website is fenestra.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address#751 Ground Floor 8th Cross 4th Main Mc Layout, Bangalore, Karnataka, India – 560040
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Fenestra Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Fenestra Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Fenestra Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Fenestra Pharmaceuticals Private Limited, buy the company report.
Financials of Fenestra Pharmaceuticals Private Limited
FY 2025 filings availableFenestra Pharmaceuticals Private Limited reported revenue of ₹11.43 Cr (up 3% YoY) for FY 2025.
Revenue · FY 2025
₹11.43 Cr ▲ 3%
Net loss · FY 2025
₹44,145 margin 0%
EBITDA · FY 2025
₹33.13 Lakh margin 2.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 3%
3 years · compounded
▲ 5%
5 years · compounded
▲ 9%
EBITDA CAGR growth
1 year
▼ 34%
3 years · compounded
▼ 23%
5 years · compounded
▲ 2%
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 3% growth in the latest year. EBITDA fell 34% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹33.13 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹44,145 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.9% | ||||
| Net Profit Margin | 0% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Fenestra Pharmaceuticals Private Limited, buy the company report.
Board of directors of Fenestra Pharmaceuticals Private Limited
Fenestra Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jayasankar Panichelparambil Gopalakrishnakurup Also directs: Fencare Pharmaceuticals Private Limited | Director | 10 Jan 2011 | 15 Years 10 Months | Current |
| Sugunanambiar Bijoy Also directs: Fencare Pharmaceuticals Private Limited | Director | 10 Jan 2011 | 15 Years 10 Months | Current |
| Nimesh Elayidath Also directs: Fencare Pharmaceuticals Private Limited | Managing Director | 10 Jan 2011 | 15 Years 10 Months | Current |
Peer comparison
Fenestra Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Genmed Shoppes Private Limited | ₹11.51 Cr (FY 2024) | 142.0% | Surat, Gujarat, India | |||
| Dermazone Pharmaceuticals Private Limited | ₹11.44 Cr (FY 2024) | 22.0% | Thane, Maharashtra, India | |||
| Saluja Medicose Private Limited | ₹11.44 Cr (FY 2025) | -1.0% | Delhi, India | |||
| Remedex Pharma Private Limited | ₹11.44 Cr (FY 2025) | 4.0% | Thiruvananthapuram, Kerala, India | |||
| Fenestra Pharmaceuticals Private Limitedthis company | ₹11.43 Cr (FY 2025) | -₹44,145 | 0% | 3.0% | 25 | Bangalore, Karnataka, India |
| Masaya Pharmaceuticals Private Limited | ₹11.4 Cr (FY 2024) | 40.0% | Kolkata, West Bengal, India | |||
| Ganga Pharma Trading Private Limited | ₹11.39 Cr (FY 2025) | -13.0% | Kolkata, West Bengal, India | |||
| Zinan Surgicals and Pharmaceuticals Private Limited | ₹11.38 Cr (FY 2024) | 47.0% | Palghar, Maharashtra, India |
To see the full peer comparison of Fenestra Pharmaceuticals Private Limited, buy the company report.
Auditor
Fenestra Pharmaceuticals Private Limited is audited by BALAN & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BALAN & CO | FY 2023 | 0340S |
Shareholding
The shareholding of Fenestra Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Fenestra Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.38 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Jan 2025 | 101053146 | Hdfc Bank Limited | ₹25 Lakh | Open | |
| 30 Jan 2025 | 101056788 | Hdfc Bank Limited | ₹25 Lakh | Open | |
| 29 Dec 2022 | 100715532 | Hdfc Bank Limited | ₹25.05 Lakh | Open | |
| 29 Dec 2022 | 100715562 | Hdfc Bank Limited | ₹25.05 Lakh | Open | |
| 29 Dec 2022 | 100722808 | Hdfc Bank Limited | ₹24.96 Lakh | Open |
Total charge records: 6 View all charges
Legal cases
No court or tribunal cases involving Fenestra Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Fenestra Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Fenestra Pharmaceuticals Private Limited has a workforce of 25 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
Employee count
25
Active EPFO establishments
1
GST
Fenestra Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AABCF6586E1ZQ | Kerala | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Fenestra Pharmaceuticals Private Limited, buy the company report.
Recent activity
Fenestra Pharmaceuticals Private Limited has 5 board changes on record since 2011: 3 appointments and 2 cessations. The latest: Lakshmi Rajeev ceased to be Director on 12 Mar 2015.
AGM
Fenestra Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Fenestra Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 25.00 Lakh with Charge ID 101053146 was registered on 30 Jan 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 25.00 Lakh with Charge ID 101056788 was registered on 30 Jan 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 25.05 Lakh with Charge ID 100715532 was registered on 29 Dec 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 25.05 Lakh with Charge ID 100715562 was registered on 29 Dec 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 24.96 Lakh with Charge ID 100722808 was registered on 29 Dec 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 13.00 Lakh with Charge ID 100505270 was registered on 09 Sep 2021.
Ceased
Lakshmi Rajeev ceased to be Director.
Ceased
Sooraj Dharmalayam ceased to be Director.
Appointed
Jayasankar Panichelparambil Gopalakrishnakurup was appointed as Director.
Appointed
Nimesh Elayidath was appointed as Managing Director.
2 earlier events are in the company report.
Frequently asked questions
Fenestra Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 January 2011 (15+ years old) and is registered under CIN U24230KA2011PTC056572.
Fenestra Pharmaceuticals has 3 current directors:
- Nimesh Elayidath - Managing Director
- Jayasankar Panichelparambil Gopalakrishnakurup - Director
- Sugunanambiar Bijoy - Director
The latest financial statements of Fenestra Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Fenestra Pharmaceuticals is 32AABCF6586E1ZQ, registered in Kerala.
The CIN (Corporate Identification Number) of Fenestra Pharmaceuticals is U24230KA2011PTC056572. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Fenestra Pharmaceuticals was incorporated on 10 January 2011, making it 15+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Fenestra Pharmaceuticals by revenue are Genmed Shoppes Private Limited, Dermazone Pharmaceuticals Private Limited, Saluja Medicose Private Limited, Remedex Pharma Private Limited, Masaya Pharmaceuticals Private Limited and 2 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Lakshmi Rajeev ceased to be Director on 12 Mar 2015. Sooraj Dharmalayam ceased to be Director on 28 Jun 2014. Jayasankar Panichelparambil Gopalakrishnakurup was appointed as Director on 10 Jan 2011. Fenestra Pharmaceuticals has 5 board changes on record in total.
Yes, Fenestra Pharmaceuticals is registered as an MSME under Udyam registration (number: UDYAM-KR-03-0167186).
Fenestra Pharmaceuticals can be reached through the website fenestra.in. Its registered office is in Bangalore, Karnataka, India.
The registered office of Fenestra Pharmaceuticals is at #751 Ground Floor 8th Cross 4th Main Mc Layout, Bangalore, Karnataka, India – 560040.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages